Dowling-degos diseaseQ82.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 22.05.2023

Dieser Artikel auf Deutsch

Synonym(s)

dark dot disease; Dark Dot Disease; Dermatosis pigmentaire reticulée des plis; Dowling-Degos disease; OMIM 179850; reticular acropigmentation; Reticulated pigmented anomaly of the flexures; Reticulate Pigmented Anomaly of the Flexures; verrucosis seborrhoica

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Dowling and Freudenthal, 1938; Degos and Ossipowski, 1954

DefinitionThis section has been translated automatically.

Very rare, sporadic but also familial, chronically progressive, genodermatosis with autosomal-dominant inheritance (different penetrance), characterized by reticular pigmentation of the intertrigines.

Occurrence/EpidemiologyThis section has been translated automatically.

Worldwide occurrence; people of Asian descent are increasingly affected; no gender preference;

EtiopathogenesisThis section has been translated automatically.

Several mutations have been identified in this phenotype. Of importance is the loss-of-function mutation in the keratin 5 gene(KRT5) located on chromosome 12q13. This gene mutation has also been described in Galli-Galli disease, the acantholytic variant of Dowling Degos disease.

Whether other disorders in the reticular hyperpigmentation group such as:

are separate entities, or different phenotypes of this mutation will emerge in the future.

Of note is the association of Dowling-Dego disease with hidradenitis suppurativa. The familial form of hidradenitis suppurativa can occur with /without signs of Dowling-Degos disease and is associated with mutations in the PSEN2 gene.

ManifestationThis section has been translated automatically.

Mostly in the 2nd half of life (2-5 years of age).

LocalizationThis section has been translated automatically.

Preferably intertriginous areas: axillae, inguinal region, lateral neck region, submammary, in the abdominal fold.

Clinical featuresThis section has been translated automatically.

Spots or flat raised, reticularly configured, hyperpigmented stains or plaques. The changes begin in the axillae and groin, and over the years spread to the neck, nape of neck and trunk of the body. In addition, often follicular hyperkeratoses; punctiform dimples perioral and nasal.

HistologyThis section has been translated automatically.

Basally hyperpigmented epithelial strands directed into the corium, branching like deer antlers but not confluent. The epidermis is slightly atrophic. Hair follicles are dilated and hyperkeratotic. The basal keratinocytes are hyerpigmented. A rare acantholytic variant is defined as Galli-Galli disease (Müller CS et al. 2009).

Differential diagnosisThis section has been translated automatically.

  • Clinical:
  • Histological:
    • Netted acanthoid type of Verruca seborrhoica: similar pattern. Clinical and histological review necessary.
    • Acanthosis nigricans: papillomatosis and hyperkeratosis, slight mostly irregular acanthosis, basal hyperpigmentation, partly pseudohorn cysts. The antler-like pattern of the reteleis is missing.

Complication(s)This section has been translated automatically.

Colonization with bacteria and Candida leads to unpleasant odors.

TherapyThis section has been translated automatically.

Therapy trials with 2-10% urea creams R102, ointments (e.g. Basodexan S Ointment, Eucerin Ointment 10% Urea) or external retinoids (e.g. R256, Isotrex Cream, Gel) are possible, but usually show only moderate success.

Progression/forecastThis section has been translated automatically.

Benign, but mostly chronic progressive course.

Note(s)This section has been translated automatically.

Remember! The identically proven gene mutations in M. Dowling-Degos and M. Galli-Galli support the thesis that they are different variants of the same disease.

DD: see also Reticular acropigmentation of Kitamura (reticulate acropigmentation of Kitamura) and Dyschromatosis symmetrica hereditaria (Dohi).

LiteratureThis section has been translated automatically.

  1. Braun-Falco M et al (2003) Enhanced cytoplasmic expression of desmocollin 3 in epidermal rete ridges of Dowling-Degos syndrome. Br J Dermatol 149: 1293-1296
  2. Betz RC et al (2006) Loss-of-function mutations in the keratin 5 gene lead to M. Dowling-Degos disease. At J Hum Genet 78: 510-519
  3. Degos R, Ossipowski B (1954) Dermatosis pigmentaire reticulee des plis (discussion de l'acanthosis nigricans). Ann Dermatol 81: 147-151
  4. Dowling GD, Freudenthal W (1938) Acanthosis nigricans. Proc Roy Soc Med 31: 1147-1150
  5. Mild P et al (1992) Dowling-Degos disease with exclusively genital manifestation. dermatologist 43: 369-372
  6. Müller CS et al (2009) Changing a concept--controversy on the confusing spectrum of the reticulatepigmented
    disorders of the skin. J Cutan Pathol 36:44-48.
  7. 1Oppolzer G et al. (1987) M. Dowling-Degos: Frustrating therapy attempt with retinoids. Dermatologist 38: 615-618
  8. Ujihara M et al (2002) Dowling-Degos disease associated with squamous cell carcinomas on the dappled pigmentation. Br J Dermatol 147: 568-571
  9. Wenzel G et al (2003) Treatment of Dowling-Degos disease with Er:YAG-laser: results after 2.5 years. Dermatol Surgery 29: 1161-1162
  10. Wenzel J et al (2002) Successful treatment of Dowling-Degos disease with Er:YAG laser. Dermatol Surgery 28: 748-750

Authors

Last updated on: 22.05.2023